Pancreatic Cancer Research

ResearcherAffiliated Hospital of Nantong UniversityActive in the last 2 years

Xiaohong Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0336-7302; OpenAlex author ID A5100451520. Sources: OpenAlex.

Their work

Papers
12 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
20
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper · 2014: 1 paper · 2015: none · 2016: 2 papers · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper

Papers 12

  1. PLAAT2 facilitates the development of pancreatic cancer and serves as a predictor of resistance to chemotherapy. Co-author DOI 10.1186/s12885-025-15481-2↗
  2. Corrigendum to "Exosomal circ_0030167 derived from BM-MSCs inhibits the invasion, migration, proliferation and stemness of pancreatic cancer cells by sponging … Co-author DOI 10.1016/j.canlet.2023.216603↗
  3. Dual-crosslinking gelatin-hyaluronic acid methacrylate based biomimetic PDAC desmoplastic niche enhances tumor-associated macrophages recruitment and M2-like p… Co-author DOI 10.1016/j.ijbiomac.2024.131826↗
  4. Biomimetic Microenvironmental Stiffness Boosts Stemness of Pancreatic Ductal Adenocarcinoma via Augmented Autophagy. Co-author DOI 10.1021/acsbiomaterials.3c00487↗
  5. Exosomal circ_0030167 derived from BM-MSCs inhibits the invasion, migration, proliferation and stemness of pancreatic cancer cells by sponging miR-338-5p and t… Co-author DOI 10.1016/j.canlet.2021.04.030↗
  6. MicroRNA-30b targets Snail to impede epithelial-mesenchymal transition in pancreatic cancer stem cells. Co-author DOI 10.7150/jca.25006↗
  7. YB-1 expression promotes pancreatic cancer metastasis that is inhibited by microRNA-216a. First author DOI 10.1016/j.yexcr.2017.07.039↗
  8. Overexpression of DIXDC1 correlates with enhanced cell growth and poor prognosis in human pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.humpath.2016.07.015↗
  9. RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis. Co-author DOI 10.1016/j.yexmp.2016.08.001↗
  10. MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cell. Co-author DOI 10.1186/1471-2407-14-85↗
  11. Knockdown of Oct4 and Nanog expression inhibits the stemness of pancreatic cancer cells. Co-author DOI 10.1016/j.canlet.2013.07.009↗
  12. [Altered expressions of embryonic stem-related genes in pancreatic cancer stem cell]. Co-author PMID 22340650↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuhua Lu · 9 shared papers, 2011–2025 · strength 1.14
  2. Yibing Guo · 6 shared papers, 2017–2024 · strength 0.86
  3. Xihao Yao · 4 shared papers, 2021–2024 · strength 0.71
  4. Qingsong Guo · 4 shared papers, 2013–2025 · strength 0.55
  5. Di Wu · 2 shared papers, 2023–2024 · strength 0.39
  6. Tiancheng Gong · 2 shared papers, 2023–2024 · strength 0.39
  7. Yingqing Mao · 2 shared papers, 2021–2024 · strength 0.33
  8. Jingjing Lu · 2 shared papers, 2017–2024 · strength 0.27
  9. Qiyang Chen · 1 shared paper, 2025 · strength 0.27
  10. Zhiwei Wang · 2 shared papers, 2017–2021 · strength 0.19
  11. Haopeng Pan · 1 shared paper, 2023 · strength 0.18
  12. Mingyan Zhu · 4 shared papers, 2011–2018 · strength 0.17
  13. Lei Wang · 3 shared papers, 2013–2018 · strength 0.14
  14. Ying Xiao · 2 shared papers, 2016 · strength 0.11
  15. Guoxiong Zhou · 2 shared papers, 2016 · strength 0.11
  16. Chunhua Wan · 2 shared papers, 2016 · strength 0.11
  17. Mingbing Xiao · 2 shared papers, 2016 · strength 0.11
  18. Yicheng Xiong · 1 shared paper, 2018 · strength 0.08
  19. Haixin Qian · 1 shared paper, 2018 · strength 0.08
  20. Zhiwei Wang · 2 shared papers, 2013–2014 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.